Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 50 Key Players companies in Hemorrhagic Fevers
by Most Market Reports in the world in 2018

The Hemorrhagic Fevers top 50 is Discovery PatSnap’ annual ranking of the top 50 Most Market Reports Hemorrhagic Fevers Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Viral hemorrhagic fevers (VHFs) are a group of illnesses caused by four families of viruses. These include the Ebola and Marburg, Lassa fever, and yellow fever viruses. VHFs have common features: they affect many organs, they damage the blood vessels, and they affect the body's ability to regulate itself. Some VHFs cause mild disease, but some, like Ebola or Marburg, cause severe disease and death.

VHFs are found around the world. Specific diseases are usually limited to areas where the animals that carry them live. For example, Lassa fever is limited to rural areas of West Africa where rats and mice carry the virus.

The risk for travelers is low, but you should avoid visiting areas where there are disease outbreaks. Because there are no effective treatments for some of these viral infections, there is concern about their use in bioterrorism.

Centers for Disease Control and Prevention

#
Company Name
Region
Tech Topics
Total
1
market report: 5
2
Medicine,Health care,Cancer,
...[+2]
market report: 5
3
Health care,Clinical trial,Drug,
...[+2]
market report: 4
4
Health care,Pharmacy and Therapeutics,Drug,
...[+2]
market report: 3
5
Health care,Cytogenetic Abnormality,Medicine,
...[+2]
market report: 3
6
Medicine,Health care,Biotechnology,
...[+2]
market report: 3
7
Hovedstaden, Denmark
Cancer immunotherapy,Health care,Medicine,
...[+2]
market report: 3
8
Clinical trial,Medicine,Pharmacy and Therapeutics,
...[+2]
market report: 3
9
market report: 3
10
Medicine,Emerging infectious disease,Synthetic vaccine,
...[+2]
market report: 3
11
Pharmacy and Therapeutics,Medicine,Staphylococcal infections,
...[+2]
market report: 3
12
market report: 3
13
Health care,Clinical trial,Drug,
...[+2]
market report: 2
14
Health care,Biopharmaceutical,Drug,
...[+2]
market report: 2
15
Basel-Stadt, Switzerland
Dosage form,Health care,Medicine,
...[+2]
market report: 2
16
Medicine,Health care,Clinical trial,
...[+2]
market report: 2
17
market report: 2
18
Biology,Medicine,Health care,
...[+2]
market report: 2
19
Medicine,Health care,Antibody,
...[+2]
market report: 2
20
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
market report: 2
21
Biotechnology,Medicine,Health care,
...[+2]
market report: 2
22
Virus,Medicine,Health care,
...[+2]
market report: 2
23
Biopharmaceutical,Medicine,Pharmacy and Therapeutics,
...[+2]
market report: 2
24
market report: 2
25
Wien, Austria
Biotechnology,Clinical trial,Health care,
...[+2]
market report: 2
26
Biological sciences,Biology,Pharmacy and Therapeutics,
...[+2]
market report: 2
27
Infection drug,Medicine,Genetic Medicine,
...[+2]
market report: 2
28
Retrovirox, Inc.
Biotechnology,Biology,Lassa fever,
...[+2]
market report: 2
29
Regimen,Medical equipment,Health care,
...[+2]
market report: 2
30
Canada
Lassa fever,Drug,Biodefense,
...[+2]
market report: 2
31
Russia
market report: 2
32
Health care,Medicine,Biopharmaceutical,
...[+2]
market report: 1
33
Medicine,Health care,Side effect,
...[+2]
market report: 1
34
Clinical trial,Cardiovascular agent,Drug,
...[+2]
market report: 1
35
Health care,Over-the-counter,Clinical trial,
...[+2]
market report: 1
36
market report: 1
37
Medicine,Health care,Therapeutic protein,
...[+2]
market report: 1
38
market report: 1
39
Angel investor,Secondary market,Medical tourism,
...[+2]
market report: 1
40
Health care,Toluene,Bromine,
...[+2]
market report: 1
41
Drug,Prescription drug,Fever drug,
...[+2]
market report: 1
42
Medicine,Pharmacy and Therapeutics,Multiple sclerosis,
...[+2]
market report: 1
43
Medicine,Pharmacy and Therapeutics,Influenza vaccine,
...[+2]
market report: 1
44
Medicine,Health care,Toxoid,
...[+2]
market report: 1
45
market report: 1
46
Clinical trial,Medicine,Health care,
...[+2]
market report: 1
47
ISCOM,Medicine,Health care,
...[+2]
market report: 1
48
market report: 1
49
Medicine,Pharmacy and Therapeutics,Robotics,
...[+2]
market report: 1
50
Vaud, Switzerland
market report: 1
Page generation time: May 17 2025